Literature DB >> 35241537

The Margins' Challenge: Risk Factors of Residual Disease After Breast Conserving Surgery in Early-stage Breast Cancer.

Piero Fregatti1,2, Marco Gipponi3, Giulia Atzori1, Raffaele DE Rosa1, Raquel Diaz1, Chiara Cornacchia1, Marco Sparavigna1, Alessandro Garlaschi4, Liliana Belgioia5,6, Alessandra Fozza5, Francesca Pitto7, Luca Boni8, Eva Blondeaux8, Francesca Depaoli2, Federica Murelli1,2, Simonetta Franchelli2, Gabriele Zoppoli9,10, Matteo Lambertini9,10,11, Daniele Friedman1,2.   

Abstract

BACKGROUND/AIM: Clinicopathological features of patients undergoing margin enlargement after lumpectomy for early breast cancer with positive/close excision margins were analyzed in order to define whether a re-operative procedure could have been avoided. Furthermore, a standardized protocol of specimen orientation was adopted in order to optimize both the widening procedure as well as the oncologic outcome. PATIENTS AND METHODS: A retrospective analysis was performed including pre-, peri-, and post-operative parameters, and a predictive score by means of a multivariate model was developed using all clinically and statistically significant variables associated with residual disease (RD).
RESULTS: RD was significantly related to positive tumor margins, hormone receptor negative, HER2-positive, and tumors with high Ki67 proliferation index (p<0.001); the corresponding contribution to the prognostic score was as follows: close margins, 3 points; hormone receptor positive disease, 2 points; low Ki67, 2 points; HER2 negativity, 1 point. In 102 patients with a score >3, only 2 patients (2.0%) had RD, while in 81 patients with a score ≤3, 55 patients (67.9%) had RD (p<0.001).
CONCLUSION: This predictive model might aid in clinical-decision making of patients with positive margins who actually require a widening procedure after intraoperative and/or definitive histology. Copyright
© 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer surgery; excision margin; intraoperative pathologic examination

Mesh:

Year:  2022        PMID: 35241537      PMCID: PMC8931907          DOI: 10.21873/invivo.12768

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  33 in total

1.  Macroscopic Evaluation of the Trimmed Frozen Block Is a Helpful Tool for Intraoperative Assessment of Resection Margins of Breast Cancer Specimens.

Authors:  Mafalda Trippel; Julia Slotta-Huspenina; Karen Becker; Tilman Rau; Stefan Paepke; Franziska Maurer-Marti; Rupert Langer
Journal:  Int J Surg Pathol       Date:  2018-06-28       Impact factor: 1.271

2.  Positive or close margins in breast conserving surgery: is re-excision always necessary?

Authors:  S O Gurdal; H Karanlik; N Cabioglu; B Ozcinar; E Yavuz; S Tuzlali; V Ozmen
Journal:  Eur J Surg Oncol       Date:  2012-03-21       Impact factor: 4.424

3.  Intraoperative inking is superior to suture marking for specimen orientation in breast cancer.

Authors:  Ariella M Altman; David D Nguyen; Benjamin Johnson; Schelomo Marmor; Molly E Klein; Todd M Tuttle; Jane Yuet Ching Hui
Journal:  Breast J       Date:  2019-09-03       Impact factor: 2.431

Review 4.  Intraoperative Margin Assessment in Breast Cancer Management.

Authors:  Chantal Reyna; Sarah M DeSnyder
Journal:  Surg Oncol Clin N Am       Date:  2018-01       Impact factor: 3.495

5.  Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.

Authors:  Tari A King; Rita Sakr; Sujata Patil; Inga Gurevich; Michelle Stempel; Michelle Sampson; Monica Morrow
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

6.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

7.  Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled Trial.

Authors:  Anees B Chagpar; Nina R Horowitz; Brigid K Killelea; Theodore Tsangaris; Peter Longley; Sonia Grizzle; Michael Loftus; Fangyong Li; Meghan Butler; Karen Stavris; Xiaopan Yao; Malini Harigopal; Veerle Bossuyt; Donald R Lannin; Lajos Pusztai; Amy J Davidoff; Cary P Gross
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

Review 8.  Margins in breast conserving surgery: A practice-changing process.

Authors:  I T Rubio; M Ahmed; T Kovacs; V Marco
Journal:  Eur J Surg Oncol       Date:  2016-02-03       Impact factor: 4.424

Review 9.  A technique for marking oncological breast tissue specimens.

Authors:  Jaison Patel; Stephanie Jenkins
Journal:  Ann Med Surg (Lond)       Date:  2016-02-24

Review 10.  DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.

Authors:  Henry M Kuerer; Benjamin D Smith; Mariana Chavez-MacGregor; Constance Albarracin; Carlos H Barcenas; Lumarie Santiago; Mary E Edgerton; Gaiane M Rauch; Sharon H Giordano; Aysegul Sahin; Savitri Krishnamurthy; Wendy Woodward; Debasish Tripathy; Wei T Yang; Kelly K Hunt
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.